These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24685766)

  • 21. Evaluation of the Case-Crossover (CCO) Study Design for Adverse Drug Event Detection.
    Burningham Z; He T; Teng CC; Zhou X; Nebeker J; Sauer BC
    Drug Saf; 2017 Sep; 40(9):789-798. PubMed ID: 28474287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Empirical performance of a new user cohort method: lessons for developing a risk identification and analysis system.
    Ryan PB; Schuemie MJ; Gruber S; Zorych I; Madigan D
    Drug Saf; 2013 Oct; 36 Suppl 1():S59-72. PubMed ID: 24166224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative outcome definitions and their effect on the performance of methods for observational outcome studies.
    Reich CG; Ryan PB; Schuemie MJ
    Drug Saf; 2013 Oct; 36 Suppl 1():S181-93. PubMed ID: 24166234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP).
    Hauben M; Aronson JK; Ferner RE
    Drug Saf; 2016 May; 39(5):421-32. PubMed ID: 26879560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug safety and big clinical data: Detection of drug-induced anaphylactic shock events.
    Bouzillé G; Osmont MN; Triquet L; Grabar N; Rochefort-Morel C; Chazard E; Polard E; Cuggia M
    J Eval Clin Pract; 2018 Jun; 24(3):536-544. PubMed ID: 29532572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Empirical performance of LGPS and LEOPARD: lessons for developing a risk identification and analysis system.
    Schuemie MJ; Madigan D; Ryan PB
    Drug Saf; 2013 Oct; 36 Suppl 1():S133-42. PubMed ID: 24166230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive values of diagnostic codes for identifying serious hypocalcemia and dermatologic adverse events among women with postmenopausal osteoporosis in a commercial health plan database.
    Wang FT; Xue F; Ding Y; Ng E; Critchlow CW; Dore DD
    BMC Health Serv Res; 2018 Apr; 18(1):263. PubMed ID: 29631582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desideratum for evidence based epidemiology.
    Overhage JM; Ryan PB; Schuemie MJ; Stang PE
    Drug Saf; 2013 Oct; 36 Suppl 1():S5-14. PubMed ID: 24166219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Empirical performance of the case-control method: lessons for developing a risk identification and analysis system.
    Madigan D; Schuemie MJ; Ryan PB
    Drug Saf; 2013 Oct; 36 Suppl 1():S73-82. PubMed ID: 24166225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ConvSCCS: convolutional self-controlled case series model for lagged adverse event detection.
    Morel M; Bacry E; Gaïffas S; Guilloux A; Leroy F
    Biostatistics; 2020 Oct; 21(4):758-774. PubMed ID: 30851046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership.
    Ryan PB; Madigan D; Stang PE; Overhage JM; Racoosin JA; Hartzema AG
    Stat Med; 2012 Dec; 31(30):4401-15. PubMed ID: 23015364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining a reference set to support methodological research in drug safety.
    Ryan PB; Schuemie MJ; Welebob E; Duke J; Valentine S; Hartzema AG
    Drug Saf; 2013 Oct; 36 Suppl 1():S33-47. PubMed ID: 24166222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possibility of Database Research as a Means of Pharmacovigilance in Japan Based on a Comparison with Sertraline Postmarketing Surveillance.
    Hirano Y; Asami Y; Kuribayashi K; Kitazaki S; Yamamoto Y; Fujimoto Y
    Value Health Reg Issues; 2018 May; 15():1-5. PubMed ID: 29474173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug Safety Monitoring in Children: Performance of Signal Detection Algorithms and Impact of Age Stratification.
    Osokogu OU; Dodd C; Pacurariu A; Kaguelidou F; Weibel D; Sturkenboom MC
    Drug Saf; 2016 Sep; 39(9):873-81. PubMed ID: 27255487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and analysis choices for safety surveillance evaluations need to be tuned to the specifics of the hypothesized drug-outcome association.
    Gruber S; Chakravarty A; Heckbert SR; Levenson M; Martin D; Nelson JC; Psaty BM; Pinheiro S; Reich CG; Toh S; Walker AM
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):973-81. PubMed ID: 27418432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medication errors: an analysis comparing PHICO's closed claims data and PHICO's Event Reporting Trending System (PERTS).
    Benjamin DM; Pendrak RF
    J Clin Pharmacol; 2003 Jul; 43(7):754-9. PubMed ID: 12856390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analyzing search behavior of healthcare professionals for drug safety surveillance.
    Odgers DJ; Harpaz R; Callahan A; Stiglic G; Shah NH
    Pac Symp Biocomput; 2015; ():306-17. PubMed ID: 25592591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A supervised adverse drug reaction signalling framework imitating Bradford Hill's causality considerations.
    Reps JM; Garibaldi JM; Aickelin U; Gibson JE; Hubbard RB
    J Biomed Inform; 2015 Aug; 56():356-68. PubMed ID: 26116429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer.
    Matsushita Y; Kuroda Y; Niwa S; Sonehara S; Hamada C; Yoshimura I
    Drug Saf; 2007; 30(8):715-26. PubMed ID: 17696584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using real-world healthcare data for pharmacovigilance signal detection - the experience of the EU-ADR project.
    Patadia VK; Coloma P; Schuemie MJ; Herings R; Gini R; Mazzaglia G; Picelli G; Fornari C; Pedersen L; van der Lei J; Sturkenboom M; Trifirò G;
    Expert Rev Clin Pharmacol; 2015 Jan; 8(1):95-102. PubMed ID: 25487079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.